Dr. Michael Torres Lizardi, MD

NPI: 1326440496
Total Payments
$667.57
2024 Payments
$475.59
Companies
5
Transactions
10
Medicare Patients
576
Medicare Billing
$106,064

Payment Breakdown by Category

Food & Beverage$667.57 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $667.57 10 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $349.89 3 $0 (2024)
Stryker Corporation $138.35 1 $0 (2018)
Olympus America Inc. $108.10 2 $0 (2024)
GlaxoSmithKline, LLC. $49.56 3 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $21.67 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $475.59 6 AstraZeneca Pharmaceuticals LP ($349.89)
2023 $31.96 2 GlaxoSmithKline, LLC. ($31.96)
2022 $21.67 1 Takeda Pharmaceuticals U.S.A., Inc. ($21.67)
2018 $138.35 1 Stryker Corporation ($138.35)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/04/2024 Olympus America Inc. Single-Use flexible Video Bronchoscope (Device) Food and Beverage In-kind items and services $59.05 General
Category: Respiratory
10/23/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $103.09 General
08/15/2024 Olympus America Inc. Spiration Valve System (Device) Food and Beverage In-kind items and services $49.05 General
Category: Endotherapy
06/26/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $120.69 General
Category: Respiratory
05/17/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $17.60 General
Category: IMMUNOLOGY
01/25/2024 AstraZeneca Pharmaceuticals LP FASENRA (Biological) Food and Beverage In-kind items and services $126.11 General
Category: Respiratory
12/05/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $16.02 General
Category: IMMUNOLOGY
01/10/2023 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $15.94 General
Category: IMMUNOLOGY
12/09/2022 Takeda Pharmaceuticals U.S.A., Inc. GLASSIA (Biological) Food and Beverage In-kind items and services $21.67 General
Category: IMMUNOLOGY
08/11/2018 Stryker Corporation DIRECT INJECT (Device) Food and Beverage Cash or cash equivalent $138.35 General
Category: NEURO

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 4 137 279 $94,730 $26,127
2021 4 250 447 $157,070 $44,646
2020 5 189 357 $128,880 $35,290
Total Patients
576
Total Services
1,083
Medicare Billing
$106,064
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 57 188 $62,040 $17,209 27.7%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 27 28 $18,200 $4,866 26.7%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 38 38 $8,740 $2,432 27.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 15 25 $5,750 $1,620 28.2%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 103 278 $91,740 $26,248 28.6%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 54 63 $40,950 $11,273 27.5%
99238 Hospital discharge day management, 30 minutes or less Facility 2021 69 70 $16,100 $4,719 29.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 24 36 $8,280 $2,406 29.1%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 46 180 $59,400 $17,103 28.8%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 62 62 $40,300 $10,013 24.8%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 26 59 $13,570 $3,845 28.3%
99238 Hospital discharge day management, 30 minutes or less Facility 2020 42 43 $9,890 $2,897 29.3%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 13 13 $5,720 $1,433 25.1%

About Dr. Michael Torres Lizardi, MD

Dr. Michael Torres Lizardi, MD is a Internal Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2014. The National Provider Identifier (NPI) number assigned to this provider is 1326440496.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Torres Lizardi, MD has received a total of $667.57 in payments from pharmaceutical and medical device companies, with $475.59 received in 2024. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($667.57).

As a Medicare-enrolled provider, Torres Lizardi has provided services to 576 Medicare beneficiaries, totaling 1,083 services with total Medicare billing of $106,064. Data is available for 3 years (2020–2022), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Hospitalist, Internal Medicine
  • Location Chicago, IL
  • Active Since 09/20/2014
  • Last Updated 05/16/2022
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1326440496

Products in Payments

  • FASENRA (Biological) $246.80
  • DIRECT INJECT (Device) $138.35
  • Single-Use flexible Video Bronchoscope (Device) $59.05
  • NUCALA (Biological) $49.56
  • Spiration Valve System (Device) $49.05
  • GLASSIA (Biological) $21.67

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Chicago